Significant Ownership of TCG Crossover GP I, LLC

Signature - Title
/s/ Craig Skaling - Craig Skaling, Authorized Signatory
Location
Palo Alto, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by TCG Crossover GP I, LLC.

Follow Filing Activity

Follow TCG Crossover GP I, LLC and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Significant Ownership of TCG Crossover GP I, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ABVX Abivax SA Ordinary Shares, par value Euro 0.01 per share 9.1% $603,774,500 7,111,596 Chen Yu 30 Sep 2025
SVRA Savara Inc. Common Stock, $0.001 par value per share 6.1% $73,184,254 12,362,205 TCG Crossover GP I, LLC 31 Dec 2025
TYRA Tyra Biosciences, Inc. Common Stock, par value $0.0001 per share 5.7% $29,792,499 2,898,103 TCG Crossover GP I, LLC 27 Feb 2025
TRDA Entrada Therapeutics, Inc. Common Stock, par value $0.0001 per share 5% $11,849,186 1,917,344 TCG Crossover GP I, LLC 19 Nov 2025
CGON CG Oncology, Inc. Common Stock, par value $0.0001 per share 4.8% $102,655,662 3,670,206 TCG Crossover GP I, LLC 31 Mar 2025
COGT Cogent Biosciences, Inc. Common Stock, par value $0.001 per share 4.8% $97,621,606 6,798,162 TCG Crossover GP I, LLC 30 Sep 2025
UPB Upstream Bio, Inc. Common Stock, par value $0.001 per share 3.9% $39,822,919 -$12,878,523 2,117,103 -24% TCG Crossover GP I, LLC 30 Sep 2025
CMPS COMPASS Pathways plc Ordinary Shares, nominal value 0.008 per share 3.9% $14,197,440 3,858,000 Chen Yu 30 Jun 2025
JBIO Jade Biosciences, Inc. Common Stock, $0.0001 par value per share 0.2% $649,193 64,023 TCG Crossover GP I, LLC 28 Apr 2025
ANTX AN2 Therapeutics, Inc. Common Stock, $0.00001 par value 0% $0 0 TCG Crossover GP I, LLC 31 Dec 2024

Schedules 13D/G Reported by TCG Crossover GP I, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .